首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2012年 4期 => 肝胆胰肿瘤 =>抗病毒联合经导管肝动脉化疗栓塞治..
抗病毒联合经导管肝动脉化疗栓塞治疗对乙型肝炎后肝硬化合并肝细胞癌患者的临床观察
Clinical study of antiviral treatment combined with transcatheter arterial chemoemholization(TACE) in patients with hepatitis B cirrhosis complicated hepatocellular carcinoma
文章发布日期:2012年03月13日  来源:  作者:辛桂杰 庄淑武 蔡艳俊等  点击次数:2716次  下载次数:586次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的探讨抗病毒联合经导管肝动脉化疗栓塞(TACE)治疗在乙型肝炎后肝硬化合并肝细胞癌(HCC)患者中的临床疗效。 方法回顾性分析抗病毒联合TACE治疗78例乙型肝炎后肝硬化合并HCC患者的临床疗效,并与同期单独行TACE患者81例对比,观察比较两组患者1、2年生存率、肝功能Child-Pugh积分及HBV DNA定量的变化。两组基线临床资料(如性别、年龄、肿瘤的大小、实验室检查及Child-Pugh评分)比较差异无统计学意义(P均>0.05)。结果治疗1、2年后,治疗组HBV DNA阴转率均显著高于对照组(P均<0.0001),肝功能Child-Pugh积分治疗组明显低于对照组 (P均<0.001),差异均有统计学意义。治疗组和对照组1、2年生存率分别为83.33%、66.67%和59.2%、36.67%(P均<0.001),差异均有统计学意义。结论应用核苷酸类似物联合TACE治疗乙型肝炎后肝硬化合并HCC的患者,可抑制HBV复制,保护患者肝功能,提高患者生存率。
【Abstract】:ObjectiveTo investigate the effects of antiviral treatment combined with transcatheter arterial chemoemholization(TACE)in patients with hepatitis B cirrhosis complicated hepatocellular carcinoma(HCC). MethodsRetrospectively analyzed the effects of antiviral treatment combined with TACE in 78 cases with Hepatitis B cirrhosis complicated HCC, and compared with 81 patients that separately used TACE at the same time. One or two years′ survival rate,Child-Pugh score and HBV DNA were measured. There were no significant differences between two groups in basic clinical materials (P>0.05)(include sex, age, tumor size, laboratory examination and Child-Pugh score). ResultsAfter one or two years′ treatment,the conversion rates of HBV DNA of treatment group were significantly higher than those of the control group(P<00001), Child-Pugh scores of treatment group were significantly lower than those of the control group(P<0.001), the differences were significantly. The one or two years′ survival rates of treatment group were 83.33% and 66.67%, while control group were 59.2% and 36.67%(P<0.001), the differences were significantly. ConclusionNucleoside analogues combined with TACE, can reduce the level of HBV DNA,protect liver functions and increase survival rates considerably in patients with hepatitis B cirrhosis complicated HCC.
【关键字】:化学栓塞,治疗性;癌, 肝细胞;肝炎,乙型
【Key words】:chemoembolization, therapeutic; carcinoma, hepatocellular; hepatitis B
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号